SonarMed

SonarMed

Airway Monitoring System | SonarMed.

HQ location
Carmel, United States
Launch date
Employees
Enterprise value
$12—18m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round

$3.0m

Series C
Total Funding000k
More about SonarMed
Made with AI
Edit

SonarMed operates in the healthcare technology sector, focusing on neonatal intensive care units (NICUs). The company offers the AirWave system, an FDA-cleared airway monitoring solution that provides continuous, real-time monitoring of endotracheal tube (ETT) movement, position, and obstruction. This technology aims to reduce complications associated with ETTs, such as unplanned extubations, which can lead to serious harm or even death in neonates.

SonarMed primarily serves hospitals and healthcare providers specializing in neonatal care. The company's business model revolves around selling the AirWave system and related services to these institutions. Revenue is generated through the sale of the monitoring devices, software subscriptions, and ongoing support services.

The market for SonarMed's products includes NICUs in hospitals globally, with a particular focus on regions with advanced healthcare systems. By addressing a critical need for improved patient safety and reducing unreimbursed hospital costs associated with ETT complications, SonarMed positions itself as a vital player in neonatal care.

Keywords: neonatal, ICU, endotracheal tube, real-time monitoring, FDA-cleared, patient safety, healthcare technology, AirWave system, unplanned extubation, hospital costs.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo